D. L. Dewi

Most-cited papers

1. Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

   N. Miyoshi, H. Ishii, H. Nagano, N. Haraguchi +15 more

   2011Cell Stem Cell782 citations Open access

   Semantic Scholar

   Save

2. The therapeutic potential of targeting tryptophan catabolism in cancer

   C. Opitz, Luis F. Somarribas Patterson, S. Mohapatra, D. L. Dewi +3 more

   2019British Journal of Cancer255 citations Open access

   Semantic Scholar

   Save

3. A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype

   Jonas Wolf, D. L. Dewi, J. Fredebohm, K. Müller-Decker +3 more

   2013Breast Cancer Research136 citations Open access

   Semantic Scholar

   Save

4. Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation

   I. Adam, D. L. Dewi, Joram Mooiweer, A. Sadik +10 more

   2018Oncoimmunology57 citations Open access

   Semantic Scholar

   Save

5. Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer

   D. L. Dewi, S. Mohapatra, Saioa Blanco Cabañes, I. Adam +18 more

   2017Oncoimmunology34 citations Open access

   Semantic Scholar

   Save

6. Autocrine Wnt regulates the survival and genomic stability of embryonic stem cells

   I. Augustin, D. L. Dewi, Jennifer Hundshammer, G. Erdmann +2 more

   2017Science Signaling28 citations

   Semantic Scholar

   Save

7. Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges

   D. L. Dewi, H. Ishii, Y. Kano, Shinpei Nishikawa +5 more

   2011Journal of gastroenterology27 citations

   Semantic Scholar

   Save

8. Immune cell recruitment in teratomas is impaired by increased Wnt secretion.

   I. Augustin, D. L. Dewi, Jennifer Hundshammer, E. Rempel +2 more

   2016Stem Cell Research21 citations Open access

   Semantic Scholar

   Save

9. Embryonic MicroRNA-369 Controls Metabolic Splicing Factors and Urges Cellular Reprograming

   M. Konno, J. Koseki, K. Kawamoto, N. Nishida +11 more

   2015PLoS ONE18 citations Open access

   Semantic Scholar

   Save

10. Transcriptomic study of dormant gastrointestinal cancer stem cells.

    Shimpei Nishikawa, D. L. Dewi, H. Ishii, M. Konno +10 more

    2012International Journal of Oncology11 citations Open access

    Semantic Scholar

    Save

11. microRNA-based cancer cell reprogramming technology.

    Shimpei Nishikawa, H. Ishii, N. Haraguchi, Y. Kano +9 more

    2012Experimental and Therapeutic Medicine11 citations Open access

    Semantic Scholar

    Save

12. Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells.

    D. L. Dewi, H. Ishii, N. Haraguchi, Shimpei Nishikawa +8 more

    2012International Journal of Molecular Medicine9 citations Open access

    Semantic Scholar

    Save

13. A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype

    Jonas Wolf, D. L. Dewi, J. Fredebohm, K. Müller-Decker +3 more

    2013Breast Cancer Research6 citations Open access

    Semantic Scholar

    Save

14. Effect of in vivo administration of reprogramming factors in the mouse liver

    A. Tomokuni, H. Eguchi, Hiromitsu Hoshino, D. L. Dewi +18 more

    2013Oncology Letters3 citations Open access

    Semantic Scholar

    Save

15. Gain-of-function oncogenic mutations in TP53 enhance defined factor-mediated cellular reprogramming

    J. Moon, H. Ishii, D. L. Dewi, Y. Kano +5 more

    20113 citations Open access

    Semantic Scholar

    Save

16. Epigenetic regulation of indoleamine-2,3-dioxygenase 1 expression in human breast cancer

    D. L. Dewi, S. Mohapatra, P. Wimberger, J. Kuhlmann +5 more

    20170 citations Open access

    Semantic Scholar

    Save

17. Cancer Stem Cell Research: Present Status and Future Perspectives

    Y. Kano, Shimpei Nishikawa, D. L. Dewi, H. Ishii +2 more

    20110 citations Open access

    Semantic Scholar

    Save